Bharat Biotech Ends Brazil Agreement With 2 Firms Amid Political Row

Drugmaker Bharat Biotech on Friday said it has scrapped agreements with two Brazilian companies amid controversy over a $324 million deal between the South American country and Bharat Biotech for the import of 20 million doses of the made-in-India COVID-19 vaccine Covaxin.

Click here for more...
from #Bangladesh #News aka Bangladesh News Now!!!